Patents by Inventor Makiko KURODA

Makiko KURODA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists
    Patent number: 9901571
    Abstract: The present invention relates to novel compounds of a formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes for their preparation, pharmaceutical compositions comprising them and their use in therapy, for example as modulators of the growth hormone secretagogue receptor (also referred to as the ghrelin receptor or GHSR-1a receptor) and/or for the treatment and/or prophylaxis of a disorder mediated by the ghrelin receptor.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: February 27, 2018
    Assignee: RaQualia Pharma Inc.
    Inventors: Yasuhiro Iwata, Kiyoshi Kawamura, Masaki Sudo, Kaoru Shimada, Shinichi Koizumi, Nobuyuki Takahashi, Keiko Obata, Makiko Kuroda
  • Serine derivatives as ghrelin receptor agonists
    Patent number: 9873695
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example as modulators of the growth hormone secretagogue receptor (also referred to as the ghrelin receptor or GHSR1a receptor) and/or for the treatment and/or prophylaxis of a disorder mediated by the ghrelin receptor.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: January 23, 2018
    Assignee: RaQualia Pharma Inc.
    Inventors: Yasuhiro Iwata, Kiyoshi Kawamura, Masaki Sudo, Kaoru Shimada, Shinichi Koizumi, Nobuyuki Takahashi, Keiko Obata, Makiko Kuroda
  • TETRAHYDROPYRAZOLOPYRIDINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS
    Publication number: 20170304277
    Abstract: The present invention relates to novel compounds of a formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes for their preparation, pharmaceutical compositions comprising them and their use in therapy, for example as modulators of the growth hormone secretagogue receptor (also referred to as the ghrelin receptor or GHSR-1a receptor) and/or for the treatment and/or prophylaxis of a disorder mediated by the ghrelin receptor.
    Type: Application
    Filed: November 2, 2015
    Publication date: October 26, 2017
    Applicant: RaQualia Pharma Inc.
    Inventors: Yasuhiro IWATA, Kiyoshi KAWAMURA, Masaki SUDO, Kaoru SHIMADA, Shinichi KOIZUMI, Nobuyuki TAKAHASHI, Keiko OBATA, Makiko KURODA
  • SERINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS
    Publication number: 20170197961
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example as modulators of the growth hormone secretagogue receptor (also referred to as the ghrelin receptor or GHSRla receptor) and/or for the treatment and/or prophylaxis of a disorder mediated by the ghrelin receptor.
    Type: Application
    Filed: August 5, 2015
    Publication date: July 13, 2017
    Applicant: RaQualia Pharma Inc.
    Inventors: Yasuhiro IWATA, Kiyoshi KAWAMURA, Masaki SUDO, Kaoru SHIMADA, Shinichi KOIZUMI, Nobuyuki TAKAHASHI, Keiko OBATA, Makiko KURODA
  • POLISHING COMPOSITION FOR SEMICONDUCTOR WAFER, PRODUCTION METHOD THEREOF, AND POLISHING METHOD
    Publication number: 20080038996
    Abstract: A polishing composition for semiconductor wafers containing colloidal silica is disclosed, wherein the colloidal silica is prepared from an active silicic acid aqueous solution obtained by removing alkali from an alkali silicate aqueous solution and a quaternary ammonium base, and is stabilized with a quaternary ammonium base. The polishing composition contains no alkali metals. The polishing composition contains a buffer solution that is a combination of a weak acid having a pKa from 8.0 to 12.5 at 25° C. (pKa is a logarithm of the reciprocal of acid dissociation constant) and a quaternary ammonium base, and exhibits a buffer action in the range from pH8 to pH11.
    Type: Application
    Filed: August 13, 2007
    Publication date: February 14, 2008
    Applicants: NIPPON CHEMICAL INDUSTRIAL CO., LTD., SPEEDFAM CO., LTD.
    Inventors: Kuniaki MAEJIMA, Shinsuke MIYABE, Masahiro IZUMI, Hiroaki TANAKA, Makiko KURODA